JP2008514203A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008514203A5 JP2008514203A5 JP2007533758A JP2007533758A JP2008514203A5 JP 2008514203 A5 JP2008514203 A5 JP 2008514203A5 JP 2007533758 A JP2007533758 A JP 2007533758A JP 2007533758 A JP2007533758 A JP 2007533758A JP 2008514203 A5 JP2008514203 A5 JP 2008514203A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- nucleic acid
- acid molecule
- filovirus
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US61388304P | 2004-09-27 | 2004-09-27 | |
| US60/613,883 | 2004-09-27 | ||
| US67760605P | 2005-05-03 | 2005-05-03 | |
| US60/677,606 | 2005-05-03 | ||
| US67976705P | 2005-05-10 | 2005-05-10 | |
| US60/679,767 | 2005-05-10 | ||
| US70169405P | 2005-07-22 | 2005-07-22 | |
| US60/701,694 | 2005-07-22 | ||
| US71587405P | 2005-09-09 | 2005-09-09 | |
| US60/715,874 | 2005-09-09 | ||
| PCT/US2005/034798 WO2006037038A1 (en) | 2004-09-27 | 2005-09-27 | Optimized vaccines to provide protection against ebola and other viruses |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008514203A JP2008514203A (ja) | 2008-05-08 |
| JP2008514203A5 true JP2008514203A5 (enExample) | 2008-11-13 |
| JP5046941B2 JP5046941B2 (ja) | 2012-10-10 |
Family
ID=35695786
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007533758A Expired - Lifetime JP5046941B2 (ja) | 2004-09-27 | 2005-09-27 | エボラ及び他のウイルスに対する防御に最適化されたワクチン |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US8101739B2 (enExample) |
| EP (1) | EP1797113B1 (enExample) |
| JP (1) | JP5046941B2 (enExample) |
| AU (1) | AU2005289439B2 (enExample) |
| CA (1) | CA2581840C (enExample) |
| IL (1) | IL182225A (enExample) |
| WO (1) | WO2006037038A1 (enExample) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102005023170A1 (de) | 2005-05-19 | 2006-11-23 | Curevac Gmbh | Optimierte Formulierung für mRNA |
| US7947286B2 (en) | 2005-10-07 | 2011-05-24 | Panthera Biopharma Llc | Drosophila cell lines producing recombinant secretable filovirus surface glycoproteins lacking the membrane spanning domain |
| US8663981B2 (en) | 2008-08-07 | 2014-03-04 | Her Majesty The Queen In Right Of Canada As Represented By The Minister Of Health | Optimized promoter sequence |
| WO2011130627A2 (en) | 2010-04-16 | 2011-10-20 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Chimpanzee adenoviral vector-based filovirus vaccines |
| CN103370411B (zh) | 2010-12-14 | 2016-05-04 | 美国卫生和人类服务部 | 腺病毒血清型26和血清型35线状病毒疫苗 |
| WO2013052456A1 (en) | 2011-10-05 | 2013-04-11 | Nanosys, Inc. | Silicon nanostructure active materials for lithium ion batteries and processes, compositions, components, and devices related thereto |
| KR102877352B1 (ko) * | 2012-04-12 | 2025-10-29 | 더 트러스티스 오브 더 유니버시티 오브 펜실베니아 | 필로바이러스 공통 항원, 이로부터 제조된 핵산 구조체 및 백신, 및 이를 사용하는 방법 |
| WO2014127478A1 (en) * | 2013-02-21 | 2014-08-28 | Children's Hospital Of Eastern Ontario Research Institute Inc. | Vaccine composition |
| ZA201608812B (en) | 2014-06-26 | 2019-08-28 | Janssen Vaccines & Prevention Bv | Antibodies and antigen-binding fragments that specifically bind to microtubule-associated protein tau |
| CA2952745A1 (en) | 2014-06-26 | 2015-12-30 | Janssen Vaccines & Prevention B.V. | Antibodies and antigen-binding fragments that specifically bind to microtubule-associated protein tau |
| SG10201901735XA (en) * | 2014-09-03 | 2019-03-28 | Bavarian Nordic As | Recombinant modified vaccinia virus ankara (mva) filovirus vaccine |
| JP2017527564A (ja) | 2014-09-03 | 2017-09-21 | バヴァリアン ノルディック エー／エス | 免疫応答の増進を目的とする方法及び組成物 |
| CN107454848B (zh) | 2014-09-03 | 2021-06-22 | 巴法里安诺迪克有限公司 | 用于诱导针对丝状病毒感染的保护性免疫的方法和组合物 |
| CA2962849A1 (en) * | 2014-12-16 | 2016-06-23 | Curevac Ag | Ebolavirus and marburgvirus vaccines |
| GB201502209D0 (en) | 2015-02-10 | 2015-03-25 | Sec Dep For Health The And Chancellor Masters And Scholars Of The University Of Oxford The And Micro | Filovirus therapy |
| EP3262411B1 (en) | 2015-02-25 | 2022-04-06 | Vanderbilt University | Antibody-mediated neutralization of marburg virus |
| WO2017172622A1 (en) * | 2016-03-28 | 2017-10-05 | Integrated Biotherapeutics, Inc. | Pan filovirus vaccine compositions and methods of making |
| WO2018011768A1 (en) | 2016-07-15 | 2018-01-18 | Janssen Vaccines And Prevention B.V. | Methods and compositions for inducing protective immunity against a marburg virus infection |
| US10925955B2 (en) | 2016-07-15 | 2021-02-23 | Janssen Vaccines & Prevention B.V. | Methods and compositions for inducing protective immunity against a Marburg virus infection |
| US11173204B2 (en) | 2017-04-06 | 2021-11-16 | Janssen Vaccines & Prevention B.V. | MVA-BN and Ad26.ZEBOV or Ad26.filo prime-boost regimen |
| EP3836961A1 (en) * | 2018-08-13 | 2021-06-23 | Janssen Vaccines & Prevention B.V. | Stabilized filovirus glycoprotein trimers |
| WO2022226060A1 (en) * | 2021-04-21 | 2022-10-27 | Vanderbilt University | Antibody cocktail for treatment of ebolavirus infections |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4631211A (en) | 1985-03-25 | 1986-12-23 | Scripps Clinic & Research Foundation | Means for sequential solid phase organic synthesis and methods using the same |
| WO1999032147A1 (en) | 1997-12-23 | 1999-07-01 | The Regents Of The University Of Michigan | Immunization for ebola virus infection |
| CA2776522C (en) * | 2001-10-01 | 2015-02-17 | The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Development of a preventive vaccine for filovirus infection in primates |
| WO2003092582A2 (en) * | 2002-04-30 | 2003-11-13 | The Trustees Of The University Of Pennsylvania | Chimeric ebola virus envelopes and uses therefor |
-
2005
- 2005-09-27 CA CA2581840A patent/CA2581840C/en active Active
- 2005-09-27 EP EP05813769.6A patent/EP1797113B1/en not_active Expired - Lifetime
- 2005-09-27 US US11/662,869 patent/US8101739B2/en active Active
- 2005-09-27 JP JP2007533758A patent/JP5046941B2/ja not_active Expired - Lifetime
- 2005-09-27 WO PCT/US2005/034798 patent/WO2006037038A1/en not_active Ceased
- 2005-09-27 AU AU2005289439A patent/AU2005289439B2/en not_active Expired
-
2007
- 2007-03-27 IL IL182225A patent/IL182225A/en active IP Right Grant
-
2012
- 2012-01-13 US US13/349,917 patent/US9012618B2/en not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008514203A5 (enExample) | ||
| US10273269B2 (en) | High potency immunogenic zika virus compositions | |
| US7528223B2 (en) | Antigens encoded by alternative reading frames from pathogenic viruses | |
| US8435535B2 (en) | Fusion proteins of HIV regulatory/accessory proteins | |
| JP2008529558A5 (enExample) | ||
| JP2010500399A5 (enExample) | ||
| JP2013501038A5 (enExample) | ||
| JP2008530245A5 (enExample) | ||
| JP2013500015A5 (enExample) | ||
| JP2019519252A5 (enExample) | ||
| JP2004518631A5 (enExample) | ||
| WO2006037038B1 (en) | Optimized vaccines to provide protection against ebola and other viruses | |
| US10729762B2 (en) | HIV immune stimulating compositions comprising recombinantly expressed pili on bacteria and methods related thereto | |
| JP2006506097A5 (enExample) | ||
| JP2004501646A5 (enExample) | ||
| WO2008154867A1 (fr) | Composé immunogénique | |
| JP2009501012A5 (enExample) | ||
| CN118791633A (zh) | 一种预防病毒性心肌炎的细菌样颗粒疫苗及其制备方法和应用 | |
| CN103298936A (zh) | 具有新型流感病毒来源的血凝素蛋白基因的重组痘苗病毒 | |
| JP2011088864A (ja) | インフルエンザウイルスに対するベクターワクチン | |
| WO2022127820A1 (zh) | 病原样抗原疫苗及其制备方法 | |
| JP5699093B2 (ja) | パラポックスウイルス・オヴィスの組換えタンパク質およびそれ由来の医薬組成物 | |
| CN119264229A (zh) | 基于SARS-CoV-2的不同奥密克戎变异型的S蛋白的疫苗和组合物 | |
| JP2014505700A (ja) | 抗原性ｇｌｙ１ポリペプチド | |
| JPWO2022246084A5 (enExample) |